ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Denali Therapeutics Inc

Denali Therapeutics Inc (DNLI)

24.37
0.16
(0.66%)
終了 8月1日 5:00AM
23.20
-1.17
( -4.80% )
プレマーケット: 8:00PM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
23.20
買値
22.03
売値
24.37
出来高
693
0.00 日の範囲 0.00
14.56 52 週間の範囲 28.35
時価総額
前日終値
24.37
始値
-
最終取引時間
19:52:27
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,153,456
発行済株式数
142,609,036
配当利回り
-
PER
-23.93
1 株当たり利益 (EPS)
-1.02
歳入
330.53M
純利益
-145.22M

Denali Therapeutics Inc について

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
1970
Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker DNLI. The last closing price for Denali Therapeutics was US$24.37. Over the last year, Denali Therapeutics shares have traded in a share price range of US$ 14.56 to US$ 28.35.

Denali Therapeutics currently has 142,609,036 shares in issue. The market capitalisation of Denali Therapeutics is US$3.48 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -23.93.

DNLI 最新ニュース

Mortgage Rates Fall Amid Volatile Activity

By Will Feuer Mortgage rates fell over the past week, as demand for homes remains volatile. In the week ending Thursday, the average rate on a 30-year fixed-rate mortgage fell to 6.33% from 6.48...

These Are The Ten Biggest Companies in Diversified Financials Industry

Diversified Financials include both consumer and commercially oriented companies. The companies in this industry offer a range of financial products and services, including lending products...

David Einhorn Sells Fannie Mae, Bets On Commodities To Beat Biden Driven Inflation

David Einhorn’s Greenlight Capital has made some big changes in Fannie Mae holdings. In his Q2 2021 letter to investors (full copy of Greenlight’s investor letter can be found here...

Barriers To GSE Reform And Homeownership Among Minorities, Low-Income

The Supreme Court has weighed in on one of the lawsuits involving Fannie Mae and Freddie Mac. However, it didn’t move the case forward much, as the court remanded the case back to the lower...

Fannie Mae COO Elected to Lilly Board

By Dave Sebastian Eli Lilly and Co. said it has elected Kimberly Johnson, the operating chief of the Federal National Mortgage Association, as a board member, effective Tuesday. The drugmaker said...

Fannie Mae, Freddie Mac Third-Quarter Earnings Rise on Mortgage Refinance Boom

By Andrew Ackerman WASHINGTON -- Government-controlled mortgage giants Fannie Mae and Freddie Mac reported improved earnings in the third quarter, as record-low interest rates fueled a refinancing...

Libor Pains Deepen as Deadline for Benchmark's Demise Approaches

By Julia-Ambra Verlaine No one said replacing the London interbank offered rate would be easy, but many regulators and investors contend the cumbersome process remains on track despite setbacks...

Borrowers Face New Fee to Cover Heightened Risks -- Update

By Andrew Ackerman Fannie Mae and Freddie Mac said they would impose a new fee to insulate themselves from losses on refinanced mortgages they guarantee, a sign of potential turbulence in the...

Borrowers Face New Fee to Cover Heightened Risks

By Andrew Ackerman Fannie Mae and Freddie Mac said they would impose a new fee to insulate themselves from losses on refinanced mortgages they guarantee, a sign of potential turbulence in the...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.58-2.4390243902423.7825.2423.575942324.24210493CS
42.1410.161443494821.0625.2420.4398271023.02286868CS
124.2922.686409307218.9125.2417.93115345621.65456383CS
267.0443.564356435616.1625.2414.56120308419.94002651CS
52-5.1-18.021201413428.328.3514.56104463820.18836481CS
156-28.18-54.846243674651.3856.814.5677059226.99723095CS
2601.717.9571893904121.4993.9412.3968797332.19947508CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BBLGBone Biologics Corporation
US$ 3.32
(53.70%)
10.75M
RDHLRedhill Biopharma Ltd
US$ 0.535
(39.29%)
11.8M
IMRXImmuneering Corporation
US$ 1.54
(36.28%)
8.09M
CDNACareDx Inc
US$ 25.51
(27.61%)
11.03k
ALMSAlumis Inc
US$ 15.00
(21.95%)
260
ALXOALX Oncology Holdings Inc
US$ 3.14
(-34.58%)
273.73k
VWEVintage Wine Estates Inc
US$ 0.035
(-32.56%)
2.48M
NCNCnoco noco Inc
US$ 0.2055
(-28.40%)
1.08M
ATECAlphatec Holdings Inc
US$ 8.20
(-18.81%)
14.74k
NVANova Minerals Limited
US$ 4.18
(-18.20%)
1
HUGEFSD Pharma Inc
US$ 0.1222
(20.99%)
41.53M
RDHLRedhill Biopharma Ltd
US$ 0.535
(39.29%)
11.8M
BBLGBone Biologics Corporation
US$ 3.32
(53.70%)
10.75M
IMRXImmuneering Corporation
US$ 1.54
(36.28%)
8.09M
NVDANVIDIA Corporation
US$ 120.15
(2.67%)
7.99M

最近閲覧した銘柄

Delayed Upgrade Clock